Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid antibodies are a heterogeneous group of autoantibodies that have clear
associations with thrombosis and pregnancy morbidity, and which together constitute the …

Currently, we use the classification criteria for antiphospholipid syndrome (APS) formulated
during the consensus conference in Sapporo and revised in Sydney 1. Classification criteria …

Given the immense antigenic load present in the microbiome, we hypothesized that
microbiota mimotopes can be a persistent trigger in human autoimmunity via cross-reactivity …

Essentials• The clinical value of IgM antibodies in thrombotic antiphospholipid syndrome
(APS) is debated.• By review of literature, we reconsidered the clinical value of IgM …

The laboratory criteria that define patients with antiphospholipid syndrome (APS) include
lupus anticoagulant (LAC), anticardiolipin antibodies and anti‐β2 glycoprotein I antibodies …

Essentials• Antibodies to domain 1 of β 2 glycoprotein I (aD1) are a subset of
antiphospholipid antibodies.• We evaluated the added diagnostic value of an automated …

Abstract Purpose of the Review This review focuses on the laboratory tests necessary for the
diagnosis of antiphospholipid syndrome (APS). For the interpretation of the results of the …

The diagnosis of antiphospholipid syndrome (APS) relies on the detection of circulating
antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LAC), anticardiolipin …

Background Antibodies binding to domain I of β2-glycoprotein I (aDI) and activated protein C
(APC) resistance are associated with an increased risk of thrombosis in cross-sectional …